IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q4 2017 Holdings

Filed 2018-02-13 | 3 holdings | $4.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$4.6M1,433,30498.2%
Juno Therapeutics, Inc.COM48205A109$85.2K1,864,1741.8%
Mabvax Therapeutics Holdings, Inc.COM NEW55414P504$1926,7080.0%